ArticleThe journal of headache and pain2026
Prediction of medication overuse in patients with migraine using cox regression and machine learning: a real-world cohort.
Article in The journal of headache and pain, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMedication overuse (MO) is a critical issue for patients with migraine, contributing to chronification and medication overuse headache (MOH). Predicting those at risk is essential for effective management. This study aims to develop and compare time-to-event prediction models for MO/MOH among patients with migraine, using a cohort from electronic health records (EHRs).
methodsA prevalent new-user design of real-world data cohort of patients with migraine conducted at Ramathibodi Hospital, Thailand, from January 2010 to December 2023. The cohort was constructed using EHR data and incorporated common predictors related to the patient, physician, and treatment. Three time-to-event models were developed: Cox proportional hazards (CPH), random survival forests (RSF), and extreme gradient boosting (XGBoost). Model performance was evaluated on a hold-out testing dataset using discrimination and calibration. Variable importance in the machine learning models was assessed using Shapley Additive Explanations.
resultsThe study included 13,082 patients with migraine, with 3,456 identified as experiencing MO/MOH, indicating an incidence rate [95% confidence interval (CI)] of 56.31 (54.44–58.21) per 1,000 patient-years. On the testing dataset, the RSF model achieved a concordance index (C-index) of 0.645 (95% CI: 0.643–0.647), slightly outperforming the CPH model’s C-index of 0.635 (95% CI: 0.634–0.636). Additionally, the RSF model recorded the lowest integrated brier score (IBS) of 0.193 (95% CI: 0.192–0.194), compared to 0.195 (95% CI: 0.194–0.196) for the CPH model. The XGBoost model demonstrated lower performance, with a C-index of 0.611 (95% CI: 0.609–0.613) and an IBS of 0.197 (95% CI: 0.195–0.199). Across all models, clinic type, physician position, and history of MO/MOH were significant predictors.
conclusionsUsing a real-world, EHR-derived cohort, we developed time-to-event prediction models incorporating multi-domain predictors to predict MO/MOH in patients with migraine. Although the models demonstrated only modest discrimination, their performance highlights the potential of CPH and machine learning algorithms in this context. External validation and the incorporation of additional clinical predictors, particularly those embedded in unstructured data, are needed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.